“…Some regions include multiple published studies. 1 = South Korea [35,36]; 2 = Kafr-el-Sheikh, Egypt [37]; 3 = Hangzhou, China [33,[38][39][40]; 4 = Niigata, Japan [41]; 5 = Guangzhou, China [42]; 6 = Laguna, Philippines [43,44]; 7 = Kagawa, Japan; 8 = Jiangsu, China; 9 = Jiangxi, China; 10 = central Japan [34]; 11 = Hiroshima, Japan; 12 = Guangxi, China [45]; 13 = Godavari, India [46,47]; 14 = Shanghai, China; 15 = Yunnan, China; 16 = Pulau Pinang, Malaysia [10,11]; 17 = Odisha, India [48]; 18 = New Delhi and Haryana, India [19,49]; 19 = Tamil Nadu, India [50]; 20 = Khin Kaen, Thailand [51]; 21 = Rajendranagar, India [52,53]; 22 = Punjab, India [47,54]; 23 = Varanasi, India [55]. Sites are listed in chronological order of published studies; 'b' indicates studies with BPH, 'w' indicates studies with WBPH.…”